Published in Eur J Cancer on November 01, 1998
Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys (2010) 2.94
Review on quality of life issues in patients with primary brain tumors. Oncologist (2010) 1.24
Health-related quality of life in patients with high-grade glioma. Neuro Oncol (2008) 1.10
Quality of life in adults with brain tumors: current knowledge and future directions. Neuro Oncol (2008) 1.09
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro Oncol (2013) 1.08
Sleep-wake circadian activity rhythm parameters and fatigue in oncology patients before the initiation of radiation therapy. Cancer Nurs (2011) 1.03
Quality of life in low-grade glioma patients receiving temozolomide. Neuro Oncol (2008) 0.95
Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol (2013) 0.94
Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus (2015) 0.91
Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03. J Neurooncol (2009) 0.91
Low-grade gliomas. Oncologist (2014) 0.90
Quality of life and brain tumors: what beyond the clinical burden? J Neurol (2014) 0.88
Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection. Neuro Oncol (2011) 0.87
Sleep-wake circadian activity rhythms and fatigue in family caregivers of oncology patients. Cancer Nurs (2011) 0.87
Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy. Oncologist (2012) 0.84
Health-related quality of life in high-grade glioma patients. Chin J Cancer (2014) 0.84
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. Cancer (2012) 0.81
Pediatric low-grade glioma survivors experience high quality of life. Childs Nerv Syst (2011) 0.81
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. Cochrane Database Syst Rev (2015) 0.81
Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. J Neurooncol (2012) 0.79
Factors influencing quality of life in adult patients with primary brain tumors. Neuro Oncol (2012) 0.79
Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas. J Neurol Neurosurg Psychiatry (2002) 0.78
The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II. Int J Mol Imaging (2011) 0.78
Life beyond a diagnosis of glioblastoma: a systematic review of the literature. J Cancer Surviv (2017) 0.77
The role of image-guided intensity modulated proton therapy in glioma. Neuro Oncol (2017) 0.75
The role of radiotherapy in the treatment of newly diagnosed supratentorial low-grade oligodendrogliomas: comparative analysis with immediate radiotherapy versus surgery alone. Cancer Res Treat (2009) 0.75
Reporting of patient-reported health-related quality of life in adults with diffuse low-grade glioma: a systematic review. Neuro Oncol (2016) 0.75
Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence. J Neurooncol (2017) 0.75
On the issue of early and aggressive treatment in grade 2 gliomas. J Cancer Res Clin Oncol (2003) 0.75
[Malignant gliomas--radiotherapy]. Wien Med Wochenschr (2006) 0.75
Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults. Adolesc Health Med Ther (2017) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med (1997) 8.72
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med (2001) 4.72
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol (1996) 3.68
The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer (1994) 3.45
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40
The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol (1992) 3.39
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol (1992) 3.30
Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther (1997) 2.92
The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer (1999) 2.78
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res (1996) 2.76
Depressive States in War. Br Med J (1941) 2.67
Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg (2007) 2.53
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet (2001) 2.44
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer (2000) 2.34
A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys (1996) 2.29
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol (1997) 2.23
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22
Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. J Pediatr (2001) 2.17
Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum (1995) 2.15
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer (2005) 2.09
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet (2002) 2.01
EAU guidelines on prostate cancer. Eur Urol (2005) 1.88
A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research. Pharmacoeconomics (1996) 1.86
Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86
Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79
Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol (1994) 1.75
Behavioral, health, and cost outcomes of an HMO-based prenatal health education program. Public Health Rep (1984) 1.74
Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol (1997) 1.72
Incomplete quality of life data in randomized trials: missing items. Stat Med (1998) 1.71
Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.69
Attitudes of terminally ill patients toward euthanasia and physician-assisted suicide. Arch Intern Med (2000) 1.68
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol (2003) 1.66
Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology (2009) 1.65
Quality of life assessment in daily clinical oncology practice: a feasibility study. Eur J Cancer (1998) 1.64
The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res (1993) 1.60
Quality of life after stroke. Impact of stroke type and lesion location. Stroke (1995) 1.59
EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys (1995) 1.59
EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol (1995) 1.58
[Alternative treatments in cancer; extent and background of utilization]. Ned Tijdschr Geneeskd (1994) 1.54
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32). Eur J Cancer (2005) 1.54
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol (2000) 1.53
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol (2000) 1.53
How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol (2000) 1.52
Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial. J Clin Oncol (2000) 1.50
Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial. Eur J Cancer (1990) 1.50
Statistical analysis of quality of life with missing data in cancer clinical trials. Stat Med (1998) 1.47
Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol (2001) 1.43
The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual Life Res (1998) 1.43
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol (1998) 1.42
Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol (1998) 1.41
[Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants]. Ned Tijdschr Geneeskd (2004) 1.38
Total glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg (1993) 1.38
The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (1997) 1.37
[Update of the study on survival with early hormonal therapy associated with radiotherapy (EORTC 22863 Study) in patients with advanced prostatic cancer. Interview with Michel Bolla]. Recenti Prog Med (2001) 1.36
Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. Br J Cancer (1999) 1.35
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol (2001) 1.33
The patient-physician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study. JAMA (2001) 1.32
The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology (2003) 1.31
Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol (1997) 1.29
Value of caregiver ratings in evaluating the quality of life of patients with cancer. J Clin Oncol (1997) 1.28
Clostridium perfringens in the environment. Appl Microbiol (1974) 1.28
Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology (2004) 1.27
Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother Oncol (2001) 1.26
Periapical status, prevalence and quality of endodontic treatment in an adult French population. Int Endod J (2002) 1.25
Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments. Radiother Oncol (1992) 1.24
A trial of consent procedures for future research with clinically derived biological samples. Br J Cancer (2009) 1.22
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer (2003) 1.22
Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol (1998) 1.21
Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke (1997) 1.21
Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med (1998) 1.21
Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer (2004) 1.21
Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys (1999) 1.18
Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. J Allergy Clin Immunol (1999) 1.18
Quality-of-life and cost-effectiveness assessment in lung cancer. Curr Opin Oncol (1995) 1.18
Communication, functional disorders and lifestyle changes after total laryngectomy. Clin Otolaryngol Allied Sci (1994) 1.17
Critical review of the international assessments of health-related quality of life. Qual Life Res (1993) 1.16
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer (2000) 1.16
Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol (1988) 1.15
Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer (2006) 1.15
Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol (2001) 1.14
Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. J Am Coll Cardiol (1983) 1.14
Perceived barriers and facilitators for general practitioner-patient communication in palliative care: a systematic review. Palliat Med (2011) 1.13
Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psychooncology (2008) 1.13
The influence of a heat and moisture exchanger (HME) on the respiratory symptoms after total laryngectomy. Clin Otolaryngol Allied Sci (1991) 1.12
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. Eur J Cancer (2008) 1.12